{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2010-N-0381\" sorted by posted_date descending", "rows": [["FDA-2010-N-0381-0057", "FDA", "FDA-2010-N-0381", "Nostrum Pharmaceuticals, LLC - Letter", "Other", "Letter(s)", "2012-09-23T04:00:00Z", 2012, 9, "2012-09-23T04:00:00Z", null, "2012-09-23T16:07:18Z", null, 0, 0, "0900006480fdb963"], ["FDA-2010-N-0381-0051", "FDA", "FDA-2010-N-0381", "Meetings: Generic Drug User Fee; Correction", "Notice", "General Notice", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:13:01Z", "2011-32562", 0, 0, "0900006480f870d0"], ["FDA-2010-N-0381-0048", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Public Meeting", "Notice", "Meeting", "2011-12-08T05:00:00Z", 2011, 12, "2011-12-08T05:00:00Z", "2012-01-07T04:59:59Z", "2011-12-08T14:13:25Z", "2011-31630", 0, 0, "0900006480f7df83"], ["FDA-2010-N-0381-0046", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Request for Comments", "Notice", "Meeting", "2011-07-22T04:00:00Z", 2011, 7, "2011-07-22T04:00:00Z", "2011-09-27T03:59:59Z", "2011-07-22T15:06:10Z", "2011-18591", 0, 0, "0900006480ec9599"], ["FDA-2010-N-0381-0042", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Extension of Comment Period", "Notice", "NEC-Notice of Extension", "2011-06-08T04:00:00Z", 2011, 6, "2011-06-08T04:00:00Z", "2011-08-02T03:59:59Z", "2011-06-08T16:37:43Z", "2011-14120", 0, 0, "0900006480e40148"], ["FDA-2010-N-0381-0041", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Public Meeting; Request for Comments", "Notice", "N-Notice", "2011-04-29T04:00:00Z", 2011, 4, "2011-04-29T04:00:00Z", "2011-06-11T03:59:59Z", "2011-04-29T14:05:42Z", "2011-10382", 0, 0, "0900006480c3bf40"], ["FDA-2010-N-0381-0038", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Notice of Public Meeting; Reopening of the Comment Period", "Notice", "NEC-Notice of Extension", "2011-03-15T04:00:00Z", 2011, 3, "2011-03-15T04:00:00Z", "2011-07-01T03:59:59Z", "2011-03-18T19:48:31Z", "2011-05917", 0, 0, "0900006480c07f7e"], ["FDA-2010-N-0381-0035", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Notice of Public Meeting; Reopening of the Comment Period", "Notice", "N-Notice", "2011-01-24T05:00:00Z", 2011, 1, "2011-01-24T05:00:00Z", "2011-02-24T04:59:59Z", "2011-02-18T18:59:02Z", "2011-01274", 0, 0, "0900006480bd126e"], ["FDA-2010-N-0381-0031", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Notice of Public Meeting; Reopening of the Comment Period", "Notice", "NEC-Notice of Extension", "2010-11-04T04:00:00Z", 2010, 11, "2010-11-04T04:00:00Z", "2010-12-07T04:59:59Z", "2010-11-22T19:01:39Z", "2010-27824", 0, 0, "0900006480b80cae"], ["FDA-2010-N-0381-0029", "FDA", "FDA-2010-N-0381", "See FDA-2010-N-0381-0032", "Supporting & Related Material", null, "2010-11-03T00:00:00Z", 2010, 11, null, null, "2012-03-24T19:34:22Z", null, 0, 1, "0900006480b70f32"], ["FDA-2010-N-0381-0030", "FDA", "FDA-2010-N-0381", "See FDA-2010-N-0381-0032", "Supporting & Related Material", null, "2010-11-03T00:00:00Z", 2010, 11, null, null, "2012-03-24T19:34:29Z", null, 0, 1, "0900006480b71758"], ["FDA-2010-N-0381-0007", "FDA", "FDA-2010-N-0381", "Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research (CDER), Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:04Z", null, 0, 0, "0900006480b6a6d4"], ["FDA-2010-N-0381-0009", "FDA", "FDA-2010-N-0381", "Brian J. Hasselbalch, Team Leader, Division of Manufacturing and Product Quality, Office of Compliance, CDER, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a6d6"], ["FDA-2010-N-0381-0011", "FDA", "FDA-2010-N-0381", "Jonah Houts, Alliance for Affordable Medicine, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a6d8"], ["FDA-2010-N-0381-0013", "FDA", "FDA-2010-N-0381", "Ahaviah Diane Glaser, American Association of Retired Persons (AARP), Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a6da"], ["FDA-2010-N-0381-0015", "FDA", "FDA-2010-N-0381", "William Vaughan, Consumers Union, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-08-11T01:37:28Z", null, 0, 0, "0900006480b6a731"], ["FDA-2010-N-0381-0005", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee Act (GDUFA) Attendee Meeting List, September 17, 2010 - List", "Other", "LST-List", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:04Z", null, 0, 0, "0900006480b6a6d2"], ["FDA-2010-N-0381-0018", "FDA", "FDA-2010-N-0381", "K.L. Spear M.D., Spear Pharmaceuticals, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:06Z", null, 0, 0, "0900006480b6a736"], ["FDA-2010-N-0381-0016", "FDA", "FDA-2010-N-0381", "Paul Brown, National Research Center(NRC) for Women and Families, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a732"], ["FDA-2010-N-0381-0019", "FDA", "FDA-2010-N-0381", "Richard J. Stec, Jr., Generic Drug User Fee Coalition Members (Apotex Corp.,Hospira Inc.,Perrigo Company, and Teva Pharmaceuticals USA), Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a734"], ["FDA-2010-N-0381-0021", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Public Meeting, September 17, 2010 - Transcript", "Other", "TR-Transcript", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:06Z", null, 0, 0, "0900006480b6a737"], ["FDA-2010-N-0381-0017", "FDA", "FDA-2010-N-0381", "Gordon Johnston, Generic Pharmaceutical Association (GPhA), Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a733"], ["FDA-2010-N-0381-0014", "FDA", "FDA-2010-N-0381", "Kasey Thompson, American Society of Health-Systems Pharmacy (ASHP), Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-08-11T03:11:10Z", null, 0, 0, "0900006480b6a6db"], ["FDA-2010-N-0381-0006", "FDA", "FDA-2010-N-0381", "Margaret Hamburg, M.D., Commissioner of Food and Drugs, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:04Z", null, 0, 0, "0900006480b6a6d3"], ["FDA-2010-N-0381-0008", "FDA", "FDA-2010-N-0381", "Helen N. Winkle, Director, Office of Pharmaceutical Science, CDER, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-08-11T03:11:09Z", null, 0, 0, "0900006480b6a6d5"], ["FDA-2010-N-0381-0020", "FDA", "FDA-2010-N-0381", "Mylan Pharmaceuticals (Heather Bresch), Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:06Z", null, 0, 0, "0900006480b6a735"], ["FDA-2010-N-0381-0012", "FDA", "FDA-2010-N-0381", "Judy Cahill, Academy of Managed Care Pharmacy, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a6d9"], ["FDA-2010-N-0381-0010", "FDA", "FDA-2010-N-0381", "Peter C. Beckerman, J.D. Senior Policy Advisor, FDA Office of Policy, Generic Drug User Fee; Public Meeting, September 17, 2010 - Presentation", "Other", "TS-Testimony", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:05Z", null, 0, 0, "0900006480b6a6d7"], ["FDA-2010-N-0381-0004", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Public Meeting, September 17, 2010 - Agenda", "Other", "LST-List", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", null, "2013-07-27T23:34:04Z", null, 0, 0, "0900006480b6a501"], ["FDA-2010-N-0381-0001", "FDA", "FDA-2010-N-0381", "Generic Drug User Fee; Public Meeting; Request for Comments", "Notice", "NM-Notice of Meeting", "2010-08-09T04:00:00Z", 2010, 8, "2010-08-09T04:00:00Z", "2010-10-18T03:59:59Z", "2010-10-07T21:10:45Z", "2010-19537", 0, 0, "0900006480b2c0f9"]], "truncated": false, "filtered_table_rows_count": 30, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2010-N-0381"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2010-N-0381", "results": [{"value": "FDA", "label": "FDA", "count": 30, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2010-N-0381", "results": [{"value": "Other", "label": "Other", "count": 19, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&document_type=Notice", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2010-N-0381", "results": [{"value": 2010, "label": 2010, "count": 22, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&posted_year=2010", "selected": false}, {"value": 2011, "label": 2011, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&posted_year=2011", "selected": false}, {"value": 2012, "label": 2012, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&posted_year=2012", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet=last_modified"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0381&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 245.14761194586754, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}